Skip to content

Application of parecoxib in multimodal analgesia after laparoscopic common bile duct exploration: a randomized controlled study

Application of parecoxib in multimodal analgesia after laparoscopic common bile duct exploration: a randomized controlled study

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030104
Enrollment
Unknown
Registered
2020-02-23
Start date
2020-02-14
Completion date
Unknown
Last updated
2020-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholelithiasis with choledocholithiasis

Interventions

experimental group:Intraoperative incision infiltration analgesia combined with timing intravenous injection of selective COX 2 inhibitor
control group:Intraoperative incision infiltration and postoperative continuous intravenous injection of opioids for analgesia

Sponsors

Xuanwu Hospital of Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patients with cholelithiasis and choledocholithiasis were treated by laparoscopic cholecystectomy combined with choledochoscopy and choledocholithotomy (primary suture or T-tube drainage). (2) 18-80 years old, mental health, intelligence level can correctly complete the pain scale evaluation. (3) We agreed and signed the operation informed consent and anesthesia analgesia informed consent, and accepted the multimodal postoperative pain relief program determined by random grouping.

Exclusion criteria

Exclusion criteria: (1) Due to the unexpected condition, the patient can not complete the established pain relief program, stop or change the established pain relief program. In case of serious operation related complications leading to death and unplanned reoperation. (2) The patients were diagnosed as malignant tumor during and after operation. (3) Patients with hepatolithiasis. (4) Patients who had ERCP and EST before. (5) Secondary acute severe biliary pancreatitis. (6) Conversion to open surgery.

Design outcomes

Primary

MeasureTime frame
Postoperative nausea;Postoperative vomiting;Postoperative dizziness;Recovery time of postoperative peristalsis;Time of landing after operation;Cost of analgesic treatment;

Secondary

MeasureTime frame
Postoperative analgesic effect;

Countries

China

Contacts

Public ContactZheng Yamin

Xuanwu Hospital of Capital Medical University

cpuzym@sina.com+86 15910688641

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026